Weekly Recap: Refinancing, revolver boost and Type 2 mix, early retention
Insulet Corporation (NASDAQ:PODD) refinanced $475M of term debt, cut margins ~25bps and expanded a $750M revolver, while rolling out Gen—2 Omnipod5/Libre3 Plus and planning Omnipod6 (2027) and a Type 2 closed—loop pivotal study (2028) amid focus on improving early retention.Previous Week RecapThis…